Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Fabio Gallazzi is active.

Publication


Featured researches published by Fabio Gallazzi.


European Journal of Immunology | 1999

Identification of destabilizing residues in HLA class II-selected bacteriophage display libraries edited by HLA-DM

Laura Raddrizzani; Elisa Bono; Anne B. Vogt; Harald Kropshofer; Fabio Gallazzi; Tiziana Sturniolo; Günter J. Hämmerling; Francesco Sinigaglia; Juergen Hammer

HLA‐DM (DM) functions as a peptide editor by catalyzing the release of class II‐associated invariant chain peptides (CLIP) and other unstable peptides, thus supporting the formation of stable class II‐peptide complexes for presentation. To investigate the general features that determine the DM susceptibility of HLA‐DR1/peptide complexes, we generated a large DM‐ensitive peptide repertoire from an M13 bacteriophage display library using a novel double selection protocol: we selected bacteriophage capable of binding to DR1 molecules and, subsequently, we enriched DR1‐bound bacteriophage susceptible to elution by purified DM molecules. Sequence and mutational analyses of the DR1/DM double‐selected peptides revealed that the amino acids Gly and Pro play a destabilizing role in the dissociation kinetics of DR1 ligands. This observation was confirmed also in natural peptide sequences such as CLIP 89 – 101, HA 307  –  319 and bovine collagen II (CII) 261–273. Our results demonstrate that DM susceptibility does not only depend on the number and nature of anchor residues, or the peptide length. Instead, less obvious sequence characteristics play a major role in the DM editing process and ultimately in the composition of peptide repertoires presented to T cells.


Nature Biotechnology | 1999

Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices

Tiziana Sturniolo; Elisa Bono; Jiayi Ding; Laura Raddrizzani; Oezlem Tuereci; Ugur Sahin; Michael Braxenthaler; Fabio Gallazzi; Maria Pia Protti; Francesco Sinigaglia; Juergen Hammer


Journal of Experimental Medicine | 1994

Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning.

Jürgen Hammer; Elisa Bono; Fabio Gallazzi; Charles Belunis; Zoltan A. Nagy; Francesco Sinigaglia


Journal of Experimental Medicine | 1995

Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association.

Jürgen Hammer; Fabio Gallazzi; Elisa Bono; R W Karr; J Guenot; P Valsasnini; Zoltan A. Nagy; Francesco Sinigaglia


Journal of Immunology | 1998

Relationship Between Peptide Selectivities of Human Transporters Associated with Antigen Processing and HLA Class I Molecules

Daniel S; Brusic; Caillat-Zucman S; Nikolai Petrovsky; Leonard C. Harrison; Riganelli D; Sinigaglia F; Fabio Gallazzi; Jürgen Hammer; van Endert Pm


Journal of Experimental Medicine | 1997

A Peptide-binding Motif for I-A g7 , the Class II Major Histocompatibility Complex (MHC) Molecule of NOD and Biozzi AB/H Mice

Leonard C. Harrison; Margo C. Honeyman; Sylvie Trembleau; Silvia Gregori; Fabio Gallazzi; Petra Augstein; Vladimir Brusic; Juergen Hammer; Luciano Adorini


Journal of Immunology | 1997

Different modes of peptide interaction enable HLA-DQ and HLA-DR molecules to bind diverse peptide repertoires.

Laura Raddrizzani; Tiziana Sturniolo; J Guenot; E Bono; Fabio Gallazzi; Z A Nagy; Francesco Sinigaglia; Jürgen Hammer


International Immunology | 2000

The motif for peptide binding to the insulin-dependent diabetes mellitus-associated class II MHC molecule I-Ag7 validated by phage display library

Silvia Gregori; Elisa Bono; Fabio Gallazzi; Juergen Hammer; Leonard C. Harrison; Luciano Adorini


Journal of Immunology | 1999

A Peptide Binding Motif for I-E g7 , the MHC Class II Molecule That Protects Eα-Transgenic Nonobese Diabetic Mice from Autoimmune Diabetes

Silvia Gregori; Sylvie Trembleau; Giuseppe Penna; Fabio Gallazzi; Juergen Hammer; George K. Papadopoulos; Luciano Adorini


Immunology Letters | 1997

The relationship between peptide selectivity of HLA class I molecules and TAP transporters

S. Daniel; Vladimir Brusic; Sophie Caillat-Zucman; N. Petrovsky; Leonard C. Harrison; D. Riganelli; Francesco Sinigaglia; Fabio Gallazzi; Jürgen Hammer; P.M. van Endert

Collaboration


Dive into the Fabio Gallazzi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Leonard C. Harrison

Walter and Eliza Hall Institute of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Silvia Gregori

Vita-Salute San Raffaele University

View shared research outputs
Top Co-Authors

Avatar

Luciano Adorini

Intercept Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge